Dividends Paid for Moderna (MRNA)
Dividends Paid for Moderna (MRNA): headline value $0. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingDividends PaidSwitch metric
Latest period
$0
YoY change
N/A
5Y CAGR
N/A
Peak year (2017)
$1.48M
Latest annual
$0
Dividends Paid history chart for Moderna (MRNA) from 2016 to 2025
Dividends Paid history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Dividends Paid | YoY |
|---|---|---|---|---|
| 2025 | $0 | — | ||
| 2024 | $0 | — | ||
| 2023 | $0 | — | ||
| 2022 | $0 | — | ||
| 2021 | $0 | — | ||
| 2020 | $0 | — | ||
| 2019 | $0 | — | ||
| 2018 | $0 | -100.0% | ||
| 2017 | $1.48M | +134.3% | ||
| 2016 | $633,000 | — |
Dividends Paid values are taken from Moderna's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Moderna (MRNA) reported dividends paid of $0.
Moderna dividends paid peaked at $1.48M in 2017; the latest annual figure is $0 in 2025 (100.0% below peak).
The highest annual dividends paid of $1.48M was reported in 2017. The lowest in the available history was $0 in 2018.
Within Healthcare, Moderna (MRNA) ranks 9th among 8 peers we track. The peer median for dividends paid is $8.05B.
Moderna Dividends Paid by Year
Moderna Dividends Paid 2025: $0
Moderna dividends paid in 2025 was $0.
Moderna Dividends Paid 2024: $0
Moderna dividends paid in 2024 was $0.
Moderna Dividends Paid 2023: $0
Moderna dividends paid in 2023 was $0.
Moderna Dividends Paid 2022: $0
Moderna dividends paid in 2022 was $0.
Moderna Dividends Paid 2021: $0
Moderna dividends paid in 2021 was $0.
See more financial history for Moderna (MRNA).
Sector peers — Dividends Paid
Companies in the same sector as Moderna, ranked by their latest dividends paid.
| Company | Dividends Paid | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $51.76B | Healthcare |
| Johnson & Johnson (JNJ) | $12.38B | Healthcare |
| AbbVie Inc. (ABBV) | $11.66B | Healthcare |
| Merck & Co., Inc. (MRK) | $8.18B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $7.92B | Healthcare |
| Eli Lilly and Company (LLY) | $5.38B | Healthcare |
| Amgen Inc. (AMGN) | $5.12B | Healthcare |
| AstraZeneca PLC (AZN) | $5.08B | Healthcare |
Frequently asked questions
What is Moderna's dividends paid?
Latest reported dividends paid for Moderna (MRNA) is $0 (period ending December 31, 2025).
When did Moderna dividends paid hit its highest annual value?
Moderna dividends paid reached its highest annual value of $1.48M in 2017.
What was Moderna dividends paid in 2024?
Moderna (MRNA) dividends paid in 2024 was $0.
What was Moderna dividends paid in 2025?
Moderna (MRNA) dividends paid in 2025 was $0.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.